News from alimera sciences, inc

14:22 ET

Alimera Sciences To Release Second Quarter 2014 Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and...

Jun 30, 2014, 07:30 ET

Alimera Sciences' ILUVIEN® Receives Positive Outcome Of Repeat-Use Procedure For 10 Additional European Countries

 Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and...

Jun 23, 2014, 23:19 ET

Alimera Sciences riceve l'autorizzazione all'immissione in commercio di ILUVIEN®, il suo farmaco per il trattamento dell'edema maculare diabetico cronico

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), una società biofarmaceutica specializzata nella ricerca, nello sviluppo e nella...

Jun 23, 2014, 07:00 ET

Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Italy For The Treatment Of Chronic Diabetic Macular Edema

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and...

May 27, 2014, 16:05 ET

Alimera Sciences To Present At Jefferies Healthcare Conference

 Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and...

May 08, 2014, 16:05 ET

Alimera Sciences Reports First Quarter 2014 Financial Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and...

May 01, 2014, 07:00 ET

Alimera Sciences To Release First Quarter 2014 Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and...

Apr 28, 2014, 07:00 ET

Alimera Sciences Signs Specialised Therapeutics Australia (STA) As Exclusive ILUVIEN® Distributor For Australia, New Zealand

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and...

Apr 25, 2014, 07:00 ET

Alimera Sciences Secures $35 Million Debt Facility

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of...

Apr 14, 2014, 07:00 ET

Alimera Sciences Announces New PDUFA Date For ILUVIEN®

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and...

Mar 27, 2014, 07:00 ET

Alimera Sciences Announces Resubmission Of ILUVIEN® New Drug Application To FDA

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of...

Feb 28, 2014, 07:30 ET

Alimera Sciences To Present At Cowen And Company 34th Annual Healthcare Conference

 Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and...

Feb 27, 2014, 16:07 ET

Alimera Sciences Reports Fourth Quarter And Full Year 2013 Financial Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and...

Feb 20, 2014, 16:05 ET

Alimera Sciences To Release Fourth Quarter And Fiscal Year 2013 Financial Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and...

Feb 13, 2014, 07:30 ET

Alimera Sciences To Present At Citi 2014 Global Healthcare Conference

 Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and...

Feb 10, 2014, 09:01 ET

Scottish Medicines Consortium Accepts ILUVIEN® For National Health Service Scotland

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and...

Feb 03, 2014, 08:20 ET

Alimera Sciences Closes $37.5 Million Private Placement

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and...

Jan 28, 2014, 06:45 ET

Alimera Sciences Announces $37.5 Million Private Placement

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development...

Jan 13, 2014, 07:00 ET

Alimera Sciences Ships First ILUVIEN® Orders For U.K. National Health Service Hospitals

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and...

Dec 18, 2013, 16:30 ET

Alimera Sciences and FDA Enter Into Labeling Discussions for ILUVIEN®, Agree Advisory Committee No Longer Necessary

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge